Evaluation of Serum CTRP-4 and CTRP-12 Levels in Hashimoto's Thyroiditis Patients: A Comparative Analysis with a Control Group and Their Correlation with Biochemical Factors

Overview

Journal Iran J Pathol

Date 2025 Mar 10

PMID 40060227

Authors

Doaa Jawad Al-Husseini

Mohsen Saravani

Shahin Nosratzehi

Hamideh Akbari

Afsaneh Shafiei

Seyyed Mehdi Jafari

Affiliations

Soon will be listed here.

Abstract

Background & Objective: Hashimoto's thyroiditis (HT) is one of the most common thyroid disorders and is characterized by manifestations attributed to thyroid gland damage and inflammatory conditions. Disturbances in thyroid hormones have physiological effects on lipoprotein metabolism and liver enzymes. CTRP family: C1q/TNF-related protein (CTRP) is an adipokine superfamily of proteins. Its essential role is anti-inflammatory activation, insulin sensitization, and regulation of blood lipids. In this study, we investigated the levels of CTRP-4 and CTRP-12 in the serum of HT patients and determined their association with biochemical factors.

Methods: The study included 60 participants, divided into HT patients and control groups. Diagnostic criteria for HT patients included anti-thyroid peroxidase antibodies (anti-TPO)>50 IU/mL. Serum levels of CTRP-4, CTRP-12, and anti-TPO were measured using an Enzyme-Linked Immunosorbent Assay.

Results: Our findings showed that the CTRP-4 and CTRP-12 levels in HT patients were higher than in the control groups (P=0.012 and P=0.003, respectively). HT patients also exhibited higher fasting blood glucose (FBG), cholesterol, TG, HDL, and LDL serum levels. Spearman's correlation analysis revealed a positive association between serum levels of CTRP-4 and CTRP-12 and anti-TPO (respectively, r= 0.295, =0.022 and r = 0.346, =0.007).

Conclusion: Our findings showed that the CTRP-4 and CTRP-12 levels in HT patients were higher than those in the control groups. These factors probably play a role in the pathogenesis of Hashimoto's thyroiditis. The clinical significance of these factors should be evaluated in future studies.

References

Enomoto T, Ohashi K, Shibata R, Higuchi A, Maruyama S, Izumiya Y . Adipolin/C1qdc2/CTRP12 protein functions as an adipokine that improves glucose metabolism. J Biol Chem. 2011; 286(40):34552-8. PMC: 3186379. DOI: 10.1074/jbc.M111.277319. View

Brazzelli V, Maffioli P, Bolcato V, Ciolfi C, DAngelo A, Tinelli C . Psoriasis and Diabetes, a Dangerous Association: Evaluation of Insulin Resistance, Lipid Abnormalities, and Cardiovascular Risk Biomarkers. Front Med (Lausanne). 2021; 8:605691. PMC: 8021695. DOI: 10.3389/fmed.2021.605691. View

Vrca V, Mayer L, Skreb F, Rahelic D, Marusic S . Antioxidant supplementation and serum lipids in patients with Graves' disease: effect on LDL-cholesterol. Acta Pharm. 2012; 62(1):115-22. DOI: 10.2478/v10007-012-0005-2. View

Huang X, Zhao J, Wang Q, Yan T, Gou S, Zhu X . Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease. CNS Neurosci Ther. 2024; 30(2):e14606. PMC: 10853890. DOI: 10.1111/cns.14606. View

Sarver D, Xu C, Cheng Y, Terrillion C, Wong G . CTRP4 ablation impairs associative learning and memory. FASEB J. 2021; 35(11):e21910. PMC: 9675051. DOI: 10.1096/fj.202100733RR. View

Tan S, Little H, Sarver D, Watkins P, Wong G . CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression. FEBS Lett. 2020; 594(19):3227-3239. PMC: 7722243. DOI: 10.1002/1873-3468.13895. View

Ragusa F, Fallahi P, Elia G, Gonnella D, Paparo S, Giusti C . Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy. Best Pract Res Clin Endocrinol Metab. 2019; 33(6):101367. DOI: 10.1016/j.beem.2019.101367. View

Amino N, Tada H, Hidaka Y, Hashimoto K . Hashimoto's disease and Dr. Hakaru Hashimoto. Endocr J. 2002; 49(4):393-7. DOI: 10.1507/endocrj.49.393. View

Radetti G . Clinical aspects of Hashimoto's thyroiditis. Endocr Dev. 2014; 26:158-70. DOI: 10.1159/000363162. View

10.

Tan B, Lewandowski K, OHare J, Randeva H . Insulin regulates the novel adipokine adipolin/CTRP12: in vivo and ex vivo effects. J Endocrinol. 2014; 221(1):111-9. DOI: 10.1530/JOE-13-0537. View

11.

Kong M, Gao Y, Guo X, Xie Y, Yu Y . Role of the CTRP family in tumor development and progression. Oncol Lett. 2021; 22(4):723. PMC: 8371956. DOI: 10.3892/ol.2021.12984. View

12.

Yetkin D, Dogantekin B . The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis. Int J Endocrinol. 2015; 2015:952729. PMC: 4433708. DOI: 10.1155/2015/952729. View

13.

Cengiz H, Demirci T, Varim C, Tamer A . The effect of Thyroid Autoimmunity on Dyslipidemia in patients with Euthyroid Hashimoto Thyroiditis. Pak J Med Sci. 2021; 37(5):1365-1370. PMC: 8377896. DOI: 10.12669/pjms.37.5.3883. View

14.

Xu W, Zhou H, Li X, Wang L, Guo X, Yin L . C1Q/TNF-related protein 4 expression correlates with herpes simplex encephalitis progression. Ann Transl Med. 2019; 7(11):235. PMC: 6603354. DOI: 10.21037/atm.2019.05.01. View

15.

Moradi N, Najafi M, Sharma T, Fallah S, Koushki M, Peterson J . Circulating levels of CTRP3 in patients with type 2 diabetes mellitus compared to controls: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2020; 169:108453. DOI: 10.1016/j.diabres.2020.108453. View

16.

Myasoedova E, Crowson C, Kremers H, Fitz-Gibbon P, Therneau T, Gabriel S . Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis. 2009; 69(7):1310-4. PMC: 2890039. DOI: 10.1136/ard.2009.122374. View

17.

Fadaei R, Moradi N, Kazemi T, Chamani E, Azdaki N, Moezibady S . Decreased serum levels of CTRP12/adipolin in patients with coronary artery disease in relation to inflammatory cytokines and insulin resistance. Cytokine. 2018; 113:326-331. DOI: 10.1016/j.cyto.2018.09.019. View

18.

Dai Y, Zhou J, Niu L, Hu J, Han J . Increased serum C1q/TNF-related protein 4 concentration in patients with acute coronary syndrome. Clin Chim Acta. 2021; 524:187-191. DOI: 10.1016/j.cca.2021.11.015. View

19.

Wang L . CTRP4: a new member of the adipocytokine family. Cell Mol Immunol. 2017; 14(10):868-870. PMC: 5649116. DOI: 10.1038/cmi.2017.83. View

20.

Jin A, Zhang Q, Yang C, Ye S, Cheng H, Zheng Y . Up-regulation of CTRP12 ameliorates hypoxia/re-oxygenation-induced cardiomyocyte injury by inhibiting apoptosis, oxidative stress, and inflammation via the enhancement of Nrf2 signaling. Hum Exp Toxicol. 2021; 40(12):2087-2098. DOI: 10.1177/09603271211021880. View